We are live on ! Find out more
CFO

Callan Family Office Portfolio holdings

AUM $5.11B
1-Year Est. Return 35.28%
This Fund
S&P 500
This Quarter Est. Return
+20.88%
1 Year Est. Return
+35.28%
3 Year Est. Return
+93.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.11B
AUM Growth
+$708M
Cap. Flow
+$113M
Cap. Flow %
2.22%
Top 10 Hldgs %
25.25%
Holding
1,262
New
131
Increased
621
Reduced
431
Closed
36

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$8.35M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$7.61M
3
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$7.26M
4
AAPL icon
Apple
AAPL
+$6.39M
5
NVDA icon
NVIDIA
NVDA
+$5.7M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$5.06M
2
WDC icon
Western Digital
WDC
+$3.02M
3
EW icon
Edwards Lifesciences
EW
+$2.63M
4
HON icon
Honeywell
HON
+$2.41M
5
BX icon
Blackstone
BX
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 25.4%
2 Miscellaneous 22.68%
3 Financials 11.9%
4 Industrials 8.79%
5 Healthcare 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UIS icon
1201
Unisys
UIS
$191M
$44.5K ﹤0.01%
12,156
+1,106
+10% +$3.47K
SANA icon
1202
Sana Biotechnology
SANA
$1.15B
$42.7K ﹤0.01%
12,224
– –
BUR icon
1203
Burford Capital
BUR
$955M
$42.3K ﹤0.01%
+10,311
New +$47.1K
COTY icon
1204
Coty
COTY
$2.58B
$38K ﹤0.01%
+17,586
New +$37.9K
TNYA icon
1205
Tenaya Therapeutics
TNYA
$153M
$37K ﹤0.01%
50,061
– –
AMC icon
1206
AMC Entertainment Holdings
AMC
$2.37B
$34.6K ﹤0.01%
18,212
+583
+3% +$1K
LXRX icon
1207
Lexicon Pharmaceuticals
LXRX
$997M
$33.8K ﹤0.01%
14,090
– –
FATE icon
1208
Fate Therapeutics
FATE
$297M
$29.5K ﹤0.01%
+10,911
New +$20.2K
SES icon
1209
SES AI
SES
$187M
$28.6K ﹤0.01%
29,780
-16,551
-36% -$18K
PROK icon
1210
ProKidney
PROK
$420M
$27.3K ﹤0.01%
13,394
– –
CLVT icon
1211
Clarivate
CLVT
$1.32B
$26K ﹤0.01%
+12,029
New +$29.4K
EHTH icon
1212
eHealth
EHTH
$31.7M
$25.7K ﹤0.01%
17,278
+240
+1% +$402
HCAT icon
1213
Health Catalyst
HCAT
$127M
$20.8K ﹤0.01%
10,449
-1,645
-14% -$2.38K
BTBT icon
1214
Bit Digital
BTBT
$591M
$18.9K ﹤0.01%
+10,474
New +$18.4K
PAAI
1215
Paradium.AI, Inc.
PAAI
$49.5M
$18.6K ﹤0.01%
+22,424
New +$38.9K
RC
1216
Ready Capital
RC
$289M
$18.5K ﹤0.01%
10,555
-8,665
-45% -$15.2K
CNDT icon
1217
Conduent
CNDT
$302M
$16.9K ﹤0.01%
11,590
-2,244
-16% -$3.48K
MYPS icon
1218
PLAYSTUDIOS Inc
MYPS
$62.5M
$15.4K ﹤0.01%
30,960
-28,882
-48% -$13.9K
GETY icon
1219
Getty Images
GETY
$98.1M
$14.8K ﹤0.01%
+17,232
New +$14.9K
TEAD
1220
Teads Holding Co
TEAD
$49.4M
$13.4K ﹤0.01%
+17,514
New +$17.2K
FSP
1221
Franklin Street Properties
FSP
$42.1M
$12.3K ﹤0.01%
23,872
-66,464
-74% -$39.3K
ARAY icon
1222
Accuray
ARAY
$31.9M
$10.9K ﹤0.01%
+42,386
New +$15.8K
ADCT icon
1223
ADC Therapeutics
ADCT
$174M
$10.8K ﹤0.01%
10,086
-2,787
-22% -$8.13K
BLNK icon
1224
Blink Charging
BLNK
$85.3M
$10.7K ﹤0.01%
16,767
– –
QSI icon
1225
Quantum-Si Incorporated
QSI
$168M
$10.7K ﹤0.01%
+12,119
New +$11.5K
47 48
49
50 51

Similar funds

BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BMO
Beck Mack & Oliver New York $5.13B AUM 11.51% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5.14B AUM 6.88% 1-Year Est. Return
SB
SIG Brokerage New York $5.15B AUM 78.53% 1-Year Est. Return

Callan Family Office's Q2 2026 Portfolio in Review

As of Q2 2026, Callan Family Office held 1,262 positions worth $5.11B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Callan Family Office's Q2 2026 filing shows 131 new, 621 increased, 431 reduced and 36 closed positions. Its largest new stake was SpaceX: 20,977 shares worth $3.58M. The largest sale was Sanofi, an estimated $5.06M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Financials.

  • Callan Family Office's largest Q2 2026 buy was SpaceX: 20,977 shares worth $3.58M.
  • Callan Family Office added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $8.35M increase.
  • Callan Family Office's biggest Q2 2026 reduction was Sanofi, cutting an estimated $5.06M.
  • Callan Family Office fully exited Coterra Energy in Q2 2026, selling an estimated $1.28M.
  • Callan Family Office's ten largest holdings make up 25% of its $5.11B portfolio in Q2 2026.
  • Callan Family Office opened 131 new positions and closed 36 in Q2 2026.
  • Callan Family Office's portfolio value rose 16% quarter-over-quarter to $5.11B.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.